skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 2
Patent #:
Issue Dt:
11/28/2000
Application #:
09251030
Filing Dt:
02/18/1999
Inventors:
ZOFIA J. CHRZAN, DAVID TOLEDO-VELASQUEZ, VINCENT WINDISCH, NARASIMHA M. VEMURI et al
Title:
STABLE NON-HYGROSCOPIC CRYSTALLINE FORM OF N-[N-[N-4-(PIPERIDIN-4-YL) BUTANOYL)-N-ETHYLGLYCYL] ASPARTYL]-L-BETA CYCLOHEXYL ALANINE AMIDE, INTERMEDIATES THEREOF, AND PREPARATION THEREOF AND OF ANTITHROMBOTIC AZACYCLOALKYLALKANOYL PEPTIDES AND PSEUDOPEPTIDES
Assignment: 1
Reel/Frame:
010866/0524Recorded: 06/06/2000Pages: 12
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
04/23/1999
Exec Dt:
02/22/1999
Exec Dt:
04/23/1999
Exec Dt:
04/03/1999
Exec Dt:
02/22/1999
Exec Dt:
02/22/1999
Exec Dt:
05/11/2000
Exec Dt:
04/21/1999
Exec Dt:
04/23/1999
Exec Dt:
04/23/1999
Exec Dt:
03/24/1999
Exec Dt:
04/20/1999
Exec Dt:
03/22/1999
Exec Dt:
04/12/1999
Exec Dt:
03/10/1999
Assignee:
500 ARCOLA ROAD
COLLEGEVILLE, PENNSYLVANIA 19426
Correspondent:
AVENTIS PHARMACEUTICALS
IRVING NEWMAN
500 ARCOLA ROAD
COLLEGEVILLE, PA 19426-0997
Assignment: 2
Reel/Frame:
010866/0980Recorded: 06/06/2000Pages: 3
Conveyance:
CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
12/15/1999
Assignee:
500 ARCOLA ROAD
COLLEGEVILLE, PENNSYLVANIA 19426
Correspondent:
AVENTIS PHARMACEUTICALS INC.
IRVING NEWMAN
PATENT DEPARTMENT, MAILSTOP #3C43
500 ARCOLA ROAD
COLLEGEVILLE, PA 19426-0997

Search Results as of: 05/09/2024 07:15 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT